Cardlytics Q1 2024 Adj EPS $(0.09) Beats $(0.11) Estimate, Sales $67.608M Miss $71.693M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cardlytics reported Q1 2024 adjusted EPS of $(0.09), surpassing the $(0.11) estimate, but its sales of $67.608M fell short of the $71.693M forecast, marking a 5.09% year-over-year increase.

May 08, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cardlytics surpassed EPS estimates but missed sales forecasts for Q1 2024, with a slight year-over-year sales increase.
Beating EPS estimates could be seen positively by investors, indicating better-than-expected profitability. However, missing sales forecasts might raise concerns about growth prospects, potentially balancing out the positive EPS impact. The modest year-over-year sales increase suggests some growth, but not at the pace analysts expected.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100